Oracle Corporation (ORCL)
NYSE: ORCL · Real-Time Price · USD
165.96
-7.00 (-4.05%)
At close: Apr 28, 2026, 4:00 PM EDT
165.76
-0.20 (-0.12%)
After-hours: Apr 28, 2026, 7:59 PM EDT
← View all transcripts

Earnings Call: Q3 2023

Mar 9, 2023

Operator

Good afternoon. My name is Emma, I will be your conference operator today. At this time, I would like to welcome everyone to the Oracle Corporation's Third Quarter 2023 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, again, press the star one. Thank you. Ken Bond, Senior VP of Investor Relations, you may begin your conference.

Ken Bond
Senior Vice President of Investor Relations, Oracle

Thank you, Emma. Good afternoon, everyone, and welcome to Oracle's third quarter fiscal year 2023 earnings conference call. A copy of the press release and financial tables, which includes a GAAP to non-GAAP reconciliation and other supplemental financial information can be viewed and downloaded from our investor relations website. A list of many customers who purchased Oracle Cloud services or went live on Oracle Cloud recently will be available from the investor relations website. On the call today, our Chairman and Chief Technology Officer, Larry Ellison, and CEO, Safra Catz. As a reminder, today's discussion will include forward-looking statements, including predictions, expectations, estimates, or other information that might be considered forward-looking. Throughout today's discussion, we will present some important factors relating to our business, which may potentially affect these forward-looking statements.

These forward-looking statements are also subject to risks and uncertainties that may cause actual results to differ materially from statements being made today. As a result, we caution you against placing undue reliance on these forward-looking statements, and we encourage you to review our most recent reports, including our 10-K and 10-Q and any applicable amendments for a complete discussion of these factors and other risks that may affect our future results or the market price of our stock. Finally, we are not obligating ourselves to revise our results or these forward-looking statements in light of new information or future events. Before taking questions, we'll begin with a few prepared remarks, and with that, I'd like to turn the call over to Safra.

Safra Catz
CEO, Oracle

Thanks, Ken. Good afternoon, everyone. Q3 represented another great quarter with continued momentum on the top and bottom line. Before I get to the numbers, I want to share with you a few thoughts that explain what's behind our continued financial success. First, our cloud offerings drive operational efficiency. In fact, one of our competitors recently coined the term the Oracle Playbook, which I absolutely love because the Oracle Playbook is all about doing more while spending less. As you all know, we started this ourselves over 20 years ago and have kept it up over all these years, resulting in the highest margins in the software business for decades. Using our own products and services enables us to increase our investments for growth while also growing profitability, including through acquisitions, as well as during our move to the cloud.

We are constantly talking with our customers about leveraging Oracle technology to accelerate their speed to market and reduce costs, all the while improving the experience they deliver to their customers. The combination of Oracle's infrastructure and apps, which is unique in the cloud market, increases the intensity of business transformation. Cloud is no longer about just renting commodity white boxes. It's about velocity and value. We have become the enterprise technology vendor of choice because we have products and services that help our customers drive cost efficiencies and modernize their businesses. Second, while AI has been dominating the recent news cycle, the truth is that our Oracle Fusion and infrastructure customers have been using AI as an integral part of their business for some time. Oracle Fusion, with embedded AI, enables customers to close their books in days, not weeks. Oracle AI provides more relevant sales leads.

Oracle AI increases infrastructure performance and security with no human intervention. Customers using OCI get AI as a service to help drive their own business transformation. Given our scale and our information advantage across industries and technologies, we are constantly training our applications to do more for our customers, whether it's further automating processes, providing critical and timely recommendations, offering insight . Or flagging potential issues. That's real enterprise AI. It's what customers are looking for. It's designed into everything we do, and that's what our customers get when they use our platform. On our Gen 2 OCI platform, the architecture and unique network capability has fast become the platform of choice for many AI companies because OCI runs workloads faster, and time is money in the cloud.

Coming to us saves our customers money. Third, customers are putting Oracle's comprehensive set of technologies to work in new and powerful ways to accelerate their businesses. The Uber win was notable because we have yet another example of an industry-transforming company concluding that Oracle's cloud performance and security exceeds that of our competitors and at a price point that represents a sustainable long-term partnership. Uber will use more of our technology to drive value in their own business, and you're gonna see a rising list of these types of strategic wins pile up in the quarters to come. Before I move to the numbers, hopefully, no one missed this fact that we're announcing our earnings nine days after the close of the quarter, and we expect to file the Q right away.

Now to the Q3 results. As always, I'll discuss them using constant currency growth rates. To provide a full picture, both organically and otherwise, I'm gonna go over the revenue results, including Cerner, and then some revenue results excluding Cerner. Total cloud revenue, that's SaaS plus IaaS, including Cerner, was $4.1 billion, up 48% in constant currency. With IaaS revenue of $1.2 billion, up 57%, and SaaS revenue of $2.9 billion, up 44%. Excluding Cerner, total cloud revenue was up 28% in constant currency at $3.5 billion.

Total cloud services and license support revenue for the quarter, including Cerner, was $8.9 billion, up 20% in constant currency, driven again by our strategic cloud applications, Autonomous Database, and our Gen 2 OCI. Application subscription revenues, which includes support, were $4.2 billion and up 33% in constant currency. Infrastructure subscription revenues, also including support, were $4.8 billion, up 10% in constant currency. Application subscription revenues, including support but excluding Cerner, were $3.4 billion, up 8% in constant currency. SaaS cloud revenue, again excluding Cerner, was $2.3 billion and was up 16%. Our strategic back-office SaaS applications now have an annualized revenue of $6.2 billion and grew 25% in constant currency, including Fusion ERP up again 28% and NetSuite ERP up 26% this quarter.

As mentioned already, infrastructure cloud services revenue was up 57% in constant currency. When you exclude our legacy hosting services, infrastructure cloud services revenue grew 65% with an annualized revenue of $4.4 billion, including OCI consumption revenue, which was up 86%, Cloud@Customer consumption revenue up 73%, and Autonomous Database up 50%. Database subscription revenues, which include database support, were up 3% in constant currency, highlighted by cloud database services, which were up 40%. Database subscription revenue is largely made up of on-premise database support. As these databases migrate from on-premise to the cloud and Cloud@Customer, we expect these cloud database services will be the third leg of revenue growth alongside back-office SaaS and Gen 2 OCI Cloud Services. Software license revenue, including Cerner, were $1.3 billion, up 4% in constant currency.

All in, total revenues for the quarter were $12.4 billion, up 21% in constant currency. Excluding Cerner's contribution of a billion and a half, organic revenue was up 7% in constant currency. As a reminder, we no longer operate in Russia, causing organic revenue growth to be negatively affected by 1% of growth over last year. Shifting to margins. The growth margin for cloud services and license support was 79% as a result of the mix between support and cloud. Last year, Oracle license support revenue, with its mid-90s gross margins, represented about 63% of cloud services and license support revenue. Because our cloud services are growing so fast, it's down to 55%. Additionally, I would note that IaaS gross margins improved substantially from last year, and I expect IaaS gross margins will continue to improve.

While we have continued to build data center capacity, we've also seen our margins go higher as these new cloud regions fill up. Most importantly, gross profit dollars of cloud services and license support grew 13% with Cerner and 6% excluding Cerner. Non-GAAP operating income was $5.2 billion, up 11% from last year. The operating margin, including Cerner, was 42% as we continued to integrate Cerner in the quarter. As we drive Cerner profitability to Oracle standards and continue to benefit from economies of scale in the cloud, we will not only continue to grow operating income, but we will also grow the operating margin percentages. For example, while we have only owned Cerner for three quarters, we have already improved its operating margin by over five percentage points compared to before the acquisition.

By the way, I actually expect this year, FY 2023, the one we are closing out in one more quarter, will be the trough year for operating margins and percentages as our margin improvement initiatives play out. The non-GAAP tax rate for the quarter was 18.4% and the non-GAAP EPS was $1.22, up 8% in USD, up 13% in constant currency. GAAP EPS was $0.68. At quarter end, we had nearly $8.8 billion in cash and marketable securities. The short-term deferred revenue balance was $8.6 billion, up 14% in constant currency. Over the last four quarters, operating cash flow was $15.5 billion, and free cash flow was $7.3 billion, with capital expenditures of $8.2 billion.

Operating cash flow for the quarter was up 11% at $4.3 billion. The remaining performance obligation, or RPO balance, is $62.3 billion, up 66% in constant currency due to strong cloud bookings as well as Cerner, which Larry will discuss in a moment. I would also note that the organic RPO growth rate was 26% in constant currency. Approximately 48% of total RPO is expected to be recognized as revenue over the next 12 months. CapEx this quarter was $2.6 billion as we continue to build capacity for existing bookings and our customers' growing needs. Given the demand you see reflected in the RPO as well as what we see in our pipeline, I expect that our CapEx investment will be about where it is right now for the foreseeable future.

As always, we remain careful to pace our investments appropriately and in line with booking trends. We now have 41 public cloud regions around the world with another eight being built. Twelve of these public cloud regions interconnect with Azure, giving customers true multi-cloud capabilities. We have many cloud customer implementations, 10 dedicated regions, and another nine national security regions with increasing demand for more. As we've said before, we are committed to returning value to our shareholders through technical innovations, strategic acquisitions, stock repurchases, prudent use of debt, and a dividend. This quarter, we repurchased 1.8 million shares for a total of $150 million. We paid out dividends of $863 million in the quarter, and the board of directors increased the quarterly dividend 25% from $0.32 to $0.40 per share.

Our financial strategy remains focused on growing non-GAAP operating and pre-tax income while substantially increasing cloud revenue growth. Given increasing customer interest in our cloud technologies, we will continue to prudently invest to meet this demand. As a reminder, because now we're going to talk about Q4, last Q4, we had a spectacular double-digit revenue growth rate, highlighted by 25% constant currency growth in software license. With our continued migration to the cloud, we expect that we will continue to win big deals that are more subscription-driven than license-driven. These big subscription wins add to the backlog and are recognized over time rather than upfront. That is exactly what we want to see as our cloud business continues to see excellent growth. Now let me turn to my guidance for Q4, which I'll provide on a non-GAAP basis.

Now, assuming that currency exchange rates remain the same as they are now, currency would have a 2% negative effect on total revenue and at least 3%+ negative effect on EPS in Q4. As I say, every quarter, the actual currency impact may be very different by quarter end. Okay, here we go. Total revenues for Q4, including Cerner, are expected to grow from 17%-19% in constant currency, and thus are expected to grow 15%-17% in USD. Total cloud growth, including Cerner, is expected to grow from 51% to 53% in constant currency, 49% to 51% in USD. I expect total cloud growth for Q4, excluding Cerner, will be above 30% in constant currency. I expect growth in operating profit to be double digits. As you all know, my non-GAAP tax rate guidance is typically 20.5%.

However, our tax rates over the last two years in Q4 have averaged around 11%, and I anticipate that in Q4, the most likely outcome is a non-GAAP tax rate of around 14.5%. We've used this rate in determining our EPS guidance for Q4. Now mind you, that's comparing it to 11 or 10.5, I think, last year. Regardless, like past quarters, the actual tax rate for Q4 could be higher or lower and affect our actual EPS. With that, non-GAAP EPS is expected to grow between 3% and 5% and be between $1.59 and $1.63 in constant currency. Non-GAAP EPS is expected to grow between 1% and 3% and be between $1.56 and $1.60 in USD. What have I got here?

Anyway, as I've said before, Cerner will be accretive to earnings this year, including Q4. With that, I'll turn it over to Larry for his comments.

Larry Ellison
Chairman and CTO, Oracle

Thank you, Safra. Since June of last year, when we acquired Cerner, that business has increased its healthcare contract base by approximately $5 billion. We have signed a diverse set of new and expanding domestic and international customers, including the US Department of Defense, the US Department of Veterans Affairs, hospital groups in 12 U.S. states, multiple hospitals in the United Kingdom, multiple provinces in Canada, the Australian Defence Forces, multiple hospitals in Puerto Rico, and multiple countries in the Middle East. While we are pleased with this early success of the Cerner business, we expect the signing of new healthcare contracts to accelerate over the next few quarters.

While the Cerner business has been booking billions of dollars in Millennium clinical and electronic health record systems for hundreds of hospitals and ambulatory clinics, the overall Oracle healthcare application portfolio is actually much broader, covering virtually the entire healthcare ecosystem. Hospitals are also buying the Oracle Fusion ERP system to manage their revenue cycle and from reimbursements, from insurance companies to patient billing, plus their medical supply chain from ordering to inventory. Hospitals are buying Fusion HCM to manage their complex, high-value workforce of doctors, nurses, and technicians. Pharmaceutical companies are buying Oracle Clinical One to manage clinical trials. Government health organizations, public health organizations are using aggregated EHR data to monitor infectious disease and respond to outbreaks quickly and efficiently.

Now, I'd like to take a couple of minutes and go over a little more specifically some of the Cerner wins since we bought the company. One A huge win at Labcorp and Ascension Health to deploy a single lab information system domain for 96 separate hospital-based labs across 10 states. Another one in Puerto Rico, Auxilio Mutuo, is an all-new electronic health record footprint to deploy in a 600+ bed academic private hospital, replacing Altera Paragon with Cerner Millennium. Vandalia Health, formerly Charleston Area Medical Center, consolidated all their EMRs into a single unified domain and added four new hospitals.

UHS modernized their revenue cycle, migrated to the CareAware cloud, and for their hospitals and ambulatory clinics. Banner Health implemented a complete revenue cycle management for, you know, for their health business. The VA deployed our unified electronic health record system to 19 additional sites. The Department of Defense deployed Oracle Cerner EHR to all the OCONUS locations in the Department of Defense, the U.S. Department of Defense. In the U.K., at the National Health Service, Sheffield Teaching Hospital deployed the full suite of Cerner applications across three additional sites in the Sheffield Teaching Hospitals.

The Princess Alexandra Hospital, also in the NHS, is a 430-bed hospital that added the full Cerner suite. Mubadala Health was the first Cerner Millennium client to move from the Cerner data center directly now to the OCI cloud. As we move our Cerner patients from the Cerner data centers into the Oracle OCI cloud, we would expect to get much better security, much better reliability, much better performance, and dramatically lower our costs of providing that cloud service. OCI is just much more efficient than the Cerner data centers that we acquired.

We've de-deployed the full EHR footprint, Cerner footprint, to four Sheikh Khalifa hospitals in the UAE, with a capacity of 1,200 beds, serving a population of 1.4 million citizens, again, in the UAE. The Australian Department of Defence, we delivered acute care capabilities and deployed an environment for all of the Australian Defence hospitals and field hospitals. In Canada, in Nova Scotia, we deployed a one patient, one record EHR system across the province for the citizens of Nova Scotia. One patient, one record. As you know, I've discussed a long time the fact that patient electronic health records are scattered across every provider they visit.

That problem is now being solved in Nova Scotia by having a single unified patient record for every patient. Regardless of which provider they visit, their records are still all in one place. Same thing in Niagara Health, a new AEHR footprint to support delivery of care for 450,000 citizens again, in Canada. Okay, I'm gonna stop with that. Those are direct Cerner wins since we acquired Cerner. On top of that, we have all of the...

If you will, the rest of the healthcare suite, which is made up of Oracle ERP, Oracle HCM, Oracle Clinical One for clinical trials, Oracle ERP for managing everything from procurement and inventory, the entire supply chain, Oracle HCM for managing the enormously complicated scheduling and paying of their professional workforce of doctors, nurses, technicians, et cetera. We're very strong in this part of the business. Our customers include the Cleveland Clinic, who use our ERP system in their hospitals and our supply chain systems. The Mayo Clinic, also ERP, supply chain, and HCM to manage the workforce. Mount Sinai Hospital, ERP, SCM, and HCM. Providence St. Joseph Health, ERP, SCM, HCM, and actually CX, customer engagement.

Adventist Health, Adventist Health uses Oracle ERP, SCM, HCM, and CX. Kaiser Permanente, a huge Oracle HCM user, to manage their workforce. The NHS in the U.K., ERP and SCM. UnitedHealthcare, ERP and HCM. Blue Cross Blue Shield, ERP, HCM, and CX. Humana, ERP and SCM. Highmark Health, ERP, SCM, all Fusion products, or HCM. Health Care Service Corporation, again, it's, you see a pattern here, ERP, HCM, and CX. Independence Blue Cross, ERP, and HCM. Bright Health Group, ERP.

In this past quarter, we had major wins at Ascension Health, buying ERP, HCM, SCM, and HCM, where the primary competitor in HCM was Workday. As we add specific features to manage the healthcare workforce, to our HCM product, Oracle becomes more and more successful in selling our HCM products within the healthcare ecosystem. Our win rates are going up dramatically, our sales cycles are going down. UT Health San Antonio was a big HCM win there. LabCorp bought ERP and HCM, where the competitor in ERP was SAP. We won BlueRock Therapeutics, where they bought ERP, SCM, and Fusion Analytics Warehouse. Again, the competitor there was SAP.

This, by the way, is a wholly owned subsidiary of Bayer AG. It was nice to win in a German company, German-owned company. ICU against SAP. ICU Medical expanded their HCM for vascular therapy and oncology. Dexcom ERP, EPM, SCM. Sitel ERP, EPM, SCM, a win over SAP. We had some huge go-lives in the quarter. Providence Health, a huge SCM customer, rolled out to 12 additional ministries. The National Healthcare in the UK supply, you know, have all the trust hospitals are all now live with ERP. Baptist Healthcare have now 10,000 employees live on HCM. Texas Children's Hospital 21,000 employees live on HCM.

I, Kelsey-Seybold Clinics, are now completely live in HCM. I can go on and on, but rather than doing that, I'm just gonna turn it over, back over to Safra.

Ken Bond
Senior Vice President of Investor Relations, Oracle

Thank you, Larry. Emma, if you could please poll the audience for questions.

Operator

Thank you. If you would like to ask a question, press star followed by 1 on your telephone keypad. Your first question today comes from the line of Mark Moerdler with Bernstein. Your line is now open.

Mark Moerdler
Managing Director, Bernstein

Thank you very much. Congratulations on the really good quarter. With the slowdown we're seeing across so many IaaS PaaS vendors over the last couple of quarters, especially this quarter, why has OCI Gen 2 held up so well? You know, you have born-in-the-cloud customers which are seeing weakness elsewhere. You have enterprises. Is it simply low price? Is it performance? Is it you're at the right time in the economic cycle to be capturing new customers? Is there some dynamics around expiry credits that are driving this? The difference is too stark. I think it's really important. The more color you can give, the better. Thanks.

Larry Ellison
Chairman and CTO, Oracle

All right. I'd like to take a crack at that. I'll start by, you know, check with Jensen at NVIDIA. He and I had a very interesting conversation. Oracle's Gen 2 cloud is quite different than the other hyperscalers. We have an RDMA network, a non-blocking RDMA network. Well, our network is very much faster than the other guy's network. What this means is, if you're running a large group of NVIDIA GPUs in a cluster doing a large AI problem at Oracle, we can build these AI clusters, these NVIDIA GPU clusters and run them. We can build those things dynamically because we use our standard network supports the clustering, the large clustering of GPUs, and allows them to communicate very quickly.

We can create these groups of GPUs. We can marshal them together. The other guys can't do that. They can build clusters, but they actually literally are physically building a new cluster. They're building new hardware. Our existing hardware, our standard network allows us to group these things together dynamically, these GPUs together dynamically to attack AI problems. No one else can do that. We have a lot of business, a lot of new AI companies coming to Oracle because we're the only ones that can run their workloads. By the way, we are cheaper. We're faster and we're cheaper. Let me give you an example where we use it ourselves. We have a partnership in healthcare, back to this healthcare thing.

We have a partnership in healthcare with MD Anderson Cancer Center, and one of our independent software vendors, called RONIN, where we build these AI, disease-specific AI modules that make recommendations to doctors about care. What they really say at MD Anderson, you know, "If we see a patient with these symptoms, this is how we respond." That's a big AI model that's built by MD Anderson working with RONIN running in the Oracle Cloud. We've actually shown, or I should say MD Anderson has actually shown, if you use this system, you reduce hospital admissions and readmissions by 30%. That's a stunning number. It's. People talk about ChatGPT being really cool 'cause it can write my high school essay for me.

Well, how about reducing hospital readmissions at MD Anderson by 30%? You decide which is more important. AI is fabulous stuff. Yeah, and ChatGPT is very cool. There are other applications other than, you know, generative language in these large language models. We've, you know, really focused on healthcare in the last, you know, year or so, since the acquisition of Cerner, and are working diligently with others to apply AI to healthcare and especially the management of the complex diseases like cancer. This is a cancer AI system. We're also doing wellness, heart disease, et cetera, you know, down the road. We think our platform runs AI very well because we create these clusters of GPUs that can attack big problems very quickly.

We do it economically, then we build the applications on top of that. We provide the service to a lot of the startups in the AI world. This is one example of where we're just way ahead of the other, the other hyperscalers in terms of our network and our ability to do AI. Let me point out one last AI thing. The Oracle Autonomous Database, you know, doesn't have any database administrators. It's completely self-driving. The Oracle Autonomous Database is self-driving because it is driven by, it is an AI module that is the DBA. We've replaced the DBAs with AI inside of our own cloud. The Oracle Autonomous Database actually it runs all the databases inside of our... the administrative part of our cloud. Keeps track of all of our users, our billing, you know, all of those things.

Recovery, recovery datasets, all of that stuff is now done using AI and our Autonomous Database. We're a huge consumer of AI. We're a huge vendor of AI GPU capacity, clustered capacity. We build AI modules in healthcare, people are coming to us. NVIDIA is often recommending us as the best cloud for AI, and this is a good time to be that.

Mark Moerdler
Managing Director, Bernstein

Perfect. Thank you.

Operator

Your next question comes from the line of Mark Murphy with JP Morgan. Your line is now open.

Mark Murphy
Executive Director, JPMorgan

Thank you, Larry. My question was very much related to that, but maybe from a slightly different angle. I'm wondering if you could drill into the opportunity that you do see on the generative AI side. We're repeatedly hearing that companies are running those kinds of models on OCI. You know, NVIDIA is moving some of those workloads to the Oracle Cloud. The other concept being that these AI models are so data hungry, and then you have all the data already contained in the Fusion applications. I am curious if that piece of it, the generative AI piece, is something that you see lining up as a, you know, growth driver that is material overall on the entire business.

Larry Ellison
Chairman and CTO, Oracle

Well, the answer is absolutely yes. There's actually more demand for AI processing than there is available capacity. we're the only ones, again, that can dynamically, by the way, we're short. We are expanding as fast as we can. You know, it's really interesting. It's an exciting opportunity, but we're, you know, it's challenging when there's more demand than supply. The difference with us is our standard network allows us to group together these GPUs and have them attack these problems, whether it's a medical diagnostic problem or it's a generative, you know, language problem, like a ChatGPT.

We have a lot of ISVs seeking us out because not only do we have the most cost-effective solution, we can make the solution available to them very quickly because it runs on our standard network. They can, we can create a cluster for them, they run their workload, and the moment their workload is through running, we can reallocate that cluster or break that cluster up and allocate it to other users. The other guys can't do that.

Mark Murphy
Executive Director, JPMorgan

Thank you.

Larry Ellison
Chairman and CTO, Oracle

They can't do it dynamically. Thank you. Next question, please, Emma.

Operator

Your next question comes from the line of Derrick Wood with TD Cowen. Your line is now open.

Derrick Wood
Managing Director, TD Cowen

Great. Thanks for taking my question. I'll echo my congratulations, especially on sustaining a very high OCI growth. Larry, one area we've been doing more work on is how cloud vendors can help transform the telco market, including migrating their IT infrastructure and their network operations to the public cloud, which should lead to greater efficiencies and also give them a more effective platform to roll out new 5G and Edge application services. I know you guys touched on this a bit at last year's Analyst Day, was just hoping to get an update on how you're thinking about that telco opportunity with the Oracle stack, especially with OCI. Who's some of the telco operators you're partnering with and how you see this playing out over the next couple of years?

Larry Ellison
Chairman and CTO, Oracle

Yeah. This is an exciting, you know, an exciting business for us. I mean, we're actually creating dedicated data centers for Vodafone. I'm not sure how many we've already built as yet, but if you will, Vodafone is moving a substantial part of their business into the Oracle Cloud. Again, we have this ability to build data centers at for customers. Those data centers are OCI data centers that we run for them, but they are dedicated to workloads at a particular customer. Nomura, the first of them we built a few years ago in Japan for Nomura. They have a primary, and now they have a backup.

They run the Tokyo Stock Exchange on that, on that, they sell it in financial services in Japan. That's an OCI data center that we built for Nomura, where they're reselling the capabilities. Vodafone is, again, another example of someone we're building dedicated data. These are OCI data centers that we run. They're in our constellation of data centers. They look like all the other OCI data centers. They're automated like all the other OCI data centers. We take advantage of those economies of scale and that skilled labor that runs them. A lot, again, a lot of it is AI, a lot of it, we still have human beings. We've done that for Vodafone.

Same thing with DISH Network's entry into telephony is enabled by the by similar architectural approach using OCI. I can go on and on. It's one of our industries of emphasis, and I think you'll see us, you know. That's gonna be a huge area of growth for us. As telcos, we've always been very strong in telcos, now they're beginning to move to the cloud. We're seeing some major commitments from some of our largest customers around the world. We're also seeing financial services companies take a slightly different point of view, but where they wanna keep things, if you will, quote on premise.

Since we can build an OCI region and dedicate it to a bank, they're, we're doing more, if you will, call it Cloud@Customer, where we build a dedicated region for a financial service. Nomura was an example, Nomura in Japan. There are other examples where we build these clouds for banks. I mean, huge industries moving to the cloud in a slightly different way than other industries. Not moving to public cloud, but rather preferring to have these dedicated regions, so it's just their applications in this cloud. We have the ability to do that. Again, the Amazon does not, and Microsoft does not, and Google does not.

Derrick Wood
Managing Director, TD Cowen

Great. Thank you.

Larry Ellison
Chairman and CTO, Oracle

Okay.

Operator

Your next question comes from the line of John DiFucci with Guggenheim. Your line is now open.

John DiFucci
Senior Managing Director, Guggenheim

Thank you. I think this question is for Safra. We've heard a lot about your committed cloud megadeals. You sometimes have talked about pure consumption or pay-as-you-go deals. Other vendors that employ the pay-as-you-go model, such as MongoDB and even Snowflake to some extent, who had been getting a ton of traction in the market, have either seen or they anticipate dramatic slowdowns. We haven't seen anything like that in your results at all, and certainly not in your guidance. Can you talk about your exposure to such deals and how they're progressing?

Safra Catz
CEO, Oracle

As, as Larry was touching on it, we have many enterprise customers, phone companies, banks, governments, who make commitments to us as part of their, as part of their move to cloud. We do have some pay-as-you-go customers, but the bulk of our revenue. First of all, our SaaS revenue, as you know, you implement an accounting system, y ou're not going to pay less tomorrow. You know, you still have to run your accounting system.

The SaaS side of the business, again, is fully committed. Then, because we have so many important enterprise customers who are bringing basically their crown jewels into our cloud and had been waiting really for us to be in the position to receive those, they wanna have a two-way commitment. They wanna know that we have the capacity for them, and they wanna get a slightly better price. First of all, those that go into the public cloud, whether it's Telecom Italia or in Verizon or some of these others, they obviously would like a better price. They make commitments to come in, usually committing less than they expect to use and almost always over using more than they expected.

However, other customers have Cloud@Customer, as Larry mentioned, or other different arrangements, the Alloy arrangement, where we have a combination with a telco or a data center provider. Those are all committed. We're very strong in the commitments from our customers. By the way, they wanna make sure we have available capacity back for them because many of them get rid of their data centers when they're finished. That's the ultimate goal for them. They don't wanna be running back and forth. These aren't toy workloads. These are critical workloads, loads for their business, and they wanna know that they've got a place to put those.

John DiFucci
Senior Managing Director, Guggenheim

The commitment is a lot of these, it sounds like these people are committed to ramping up.

Safra Catz
CEO, Oracle

Yes.

John DiFucci
Senior Managing Director, Guggenheim

-to the full capacity of their data center, and not until they do that do they shut down, for the most part, t he data center.

Safra Catz
CEO, Oracle

Yeah.

John DiFucci
Senior Managing Director, Guggenheim

They're replacing. Okay.

Safra Catz
CEO, Oracle

Yeah.

John DiFucci
Senior Managing Director, Guggenheim

Okay. Awesome.

Safra Catz
CEO, Oracle

Okay. Just so that we're clear here, pay-as-you-go at Oracle is less than 5% of our business. Okay.

Larry Ellison
Chairman and CTO, Oracle

Okay.

Safra Catz
CEO, Oracle

It's. Okay. Is that clear?

Larry Ellison
Chairman and CTO, Oracle

That's very clear. Thank you very much, Safra.

Safra Catz
CEO, Oracle

Okay.

Operator

Your last question today comes from the line of Brad Zelnick with Deutsche Bank. Your line is now open.

Brad Zelnick
Managing Director, Deutsche Bank

Excellent. Thank you so much for taking my question. Larry, as I think about the strong momentum in Cerner, expanding the contract base by $5 billion and your expectations for the business to accelerate, can you parse through the drivers in terms of new logo win rates versus the expansion in cross-sell you're doing with Fusion, for example? Then also, Larry, you touched on the idea of a single medical record. People have been talking about this for decades. When does it become clear that Oracle is helping improve the quality of care and saving lives? I've got a quick follow-up for Safra, if Ken will allow.

Larry Ellison
Chairman and CTO, Oracle

I think there are two things. One is the system we're putting in for the DoD and for the VA is one patient, one record. That's a model of it. The one we're going in in Nova Scotia is the same. We are bidding on a huge contract for the NHS. Again, some of these contracts are enormous, and the responsibility to go along with the contracts is also enormous. Our system, that's how our system works. Our standard system that we have built is one, you know, one patient, one record in the database.

If you visit Stanford and UCLA and Mayo Clinic and Cleveland Clinic, even if you go to those four different providers for a variety of different issues, all of your data will be in one database. All your patient data will be in one place, immediately accessible in a time of emergency or just a routine visit to the doctor. That's how our system is architected. That's how we're delivering it to customers. To customers right now, it's attracted a lot of attention. Actually, it's not only much better for the patient, but it helps deliver better, give doctors better information, deliver better outcomes, but it's also less expensive to do it that way than every hospital maintaining their own system.

Rather, it's better that they should share a system in the cloud, and integrate their data to, for the benefit of the patient.

Saving lives is exactly what's, you know, what's happening with our partner at RONIN and our partner at MD Anderson, and other partnerships I could go into in more detail, and I'm happy to, but not on this call, is these disease-specific AI modules where and the telemedicine modules that we're delivering, allows a patient in a community hospital in Montana to get the benefits of the wisdom of the best cancer specialists at MD Anderson Hospital in Texas, or Memorial Sloan Kettering doc in New York, or Mass General doctor who's on faculty at Harvard Medical School.

The fact that we're now using AI and telemedicine and instrumenting these diagnostic devices, so the docs, you know, in the community hospital, we have diagnostic devices that the Harvard faculty member at Mass General can look at, and then they inspect the AI module to gather much better information, and with that better information, have the best minds and AI, real minds and artificial intelligence processing that information and prescribing, hopefully the best procedure or the best medication for that particular patient, which translates into reducing readmissions to the hospital as it did at MD Anderson and ultimately saving lives.

Brad Zelnick
Managing Director, Deutsche Bank

Thank you so much for that, Larry. The mission is so important. If I could just sneak in a quick one for Safra to follow up. Safra, 30% organic cloud growth for the year implies significant acceleration in Q4. What supports your confidence in delivering that? Thank you so much.

Safra Catz
CEO, Oracle

Well, remember, as I told you, we have dropped a large number of data centers. As they become available, we have customers waiting to get started and use them. We have commitments from customers to quite an enormous amount of consumption. They've basically been waiting for us. We've taken a while in all these different countries to open these data centers and to make them available to our customers. We know they are actually very impatient to use the capacity as it becomes available. We just have a lot of momentum and a lot of commitment from our customers and a lot of enthusiasm around our offerings. That's how the math works.

Brad Zelnick
Managing Director, Deutsche Bank

Excellent. Thank you.

Ken Bond
Senior Vice President of Investor Relations, Oracle

Thank you, Brad and Safra. A telephonic replay of this conference call will be available for 24 hours on our investor relations website. Thank you for joining us today. With that, I'll turn the call back to Emma for closing.

Operator

Thank you. This concludes today's conference call. Thank you for attending.

Powered by